- call +1-201-465-4211
- email sales@mrinsights.biz
Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.
A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.
Scope of the Report:
The top players cover Hitachi Medical Corporation, Siemen Healthineers, Philips Healthcare and GE Healthcare etc., which are playing important roles in global Breast Cancer Screening market.
At present, global economy is fluctuant, and most countries take measures to stimulate the economy, especially in Rest of Asia, Europe, Australia and the resources providing countries, like Russia, Middle East, Brazil etc. In many fields, China is the largest consumer, but in the past several years, China's economic growth slows. The China government is reforming the economic structure, to release energy of economy. USA economy is relatively stable with low-speed-growth, but in future, it also is full of risk. In Southeast Asia, the economy also is fluctuated the economic base is comparatively unsubstantial, due to the exchange fluctuations. In India, although many people look to further increase in India, but the economic aggregate is too low and the infrastructure is behindhand and inefficient. In a long term, India will keep a stable and low growth in economy, due to its economic structure and bureaucratic system.
On the other hand, the political factors, like government succession, security fears, trade dispute, domestic employment, even the regional military crisis, always affect the economic activity, country to country, corporation to country. So it needs us with deep insight, to analyze the prospect avoid risk, to grasp the opportunity and reduce losses.
The worldwide market for Breast Cancer Screening is expected to grow at a CAGR of roughly 8.4% over the next five years, will reach 2310 million US$ in 2024, from 1430 million US$ in 2019, according to a new study.
This report focuses on the Breast Cancer Screening in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Hologic
GE Healthcare
Siemen Healthineers
Philips Healthcare
Canon Medical
Fujifilm
Metaltronica
Sino Medical-Device
IMS Srl
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Mammography Screening
Breast Magnetic Resonance Imaging (MRI) Screening
Breast Ultrasound Screening
Market Segment by Applications, can be divided into
Hospital
Clinic
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Breast Cancer Screening product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Breast Cancer Screening, with price, sales, revenue and global market share of Breast Cancer Screening in 2017 and 2018.
Chapter 3, the Breast Cancer Screening competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Breast Cancer Screening breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Breast Cancer Screening market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Breast Cancer Screening sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Breast Cancer Screening Introduction
1.2 Market Analysis by Type
1.2.1 Mammography Screening
1.2.2 Breast Magnetic Resonance Imaging (MRI) Screening
1.2.3 Breast Ultrasound Screening
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hologic
2.1.1 Business Overview
2.1.2 Breast Cancer Screening Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hologic Breast Cancer Screening Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 GE Healthcare
2.2.1 Business Overview
2.2.2 Breast Cancer Screening Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GE Healthcare Breast Cancer Screening Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Siemen Healthineers
2.3.1 Business Overview
2.3.2 Breast Cancer Screening Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Siemen Healthineers Breast Cancer Screening Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Philips Healthcare
2.4.1 Business Overview
2.4.2 Breast Cancer Screening Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Philips Healthcare Breast Cancer Screening Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Canon Medical
2.5.1 Business Overview
2.5.2 Breast Cancer Screening Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Canon Medical Breast Cancer Screening Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Fujifilm
2.6.1 Business Overview
2.6.2 Breast Cancer Screening Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Fujifilm Breast Cancer Screening Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Metaltronica
2.7.1 Business Overview
2.7.2 Breast Cancer Screening Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Metaltronica Breast Cancer Screening Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Sino Medical-Device
2.8.1 Business Overview
2.8.2 Breast Cancer Screening Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sino Medical-Device Breast Cancer Screening Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 IMS Srl
2.9.1 Business Overview
2.9.2 Breast Cancer Screening Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 IMS Srl Breast Cancer Screening Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Breast Cancer Screening Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Breast Cancer Screening Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Breast Cancer Screening Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Breast Cancer Screening Manufacturer Market Share in 2018
3.3.2 Top 6 Breast Cancer Screening Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Breast Cancer Screening Market Analysis by Regions
4.1 Global Breast Cancer Screening Sales, Revenue and Market Share by Regions
4.1.1 Global Breast Cancer Screening Sales and Market Share by Regions (2014-2019)
4.1.2 Global Breast Cancer Screening Revenue and Market Share by Regions (2014-2019)
4.2 North America Breast Cancer Screening Sales and Growth Rate (2014-2019)
4.3 Europe Breast Cancer Screening Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Breast Cancer Screening Sales and Growth Rate (2014-2019)
4.5 South America Breast Cancer Screening Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Breast Cancer Screening Sales and Growth Rate (2014-2019)
5 North America Breast Cancer Screening by Country
5.1 North America Breast Cancer Screening Sales, Revenue and Market Share by Country
5.1.1 North America Breast Cancer Screening Sales and Market Share by Country (2014-2019)
5.1.2 North America Breast Cancer Screening Revenue and Market Share by Country (2014-2019)
5.2 United States Breast Cancer Screening Sales and Growth Rate (2014-2019)
5.3 Canada Breast Cancer Screening Sales and Growth Rate (2014-2019)
5.4 Mexico Breast Cancer Screening Sales and Growth Rate (2014-2019)
6 Europe Breast Cancer Screening by Country
6.1 Europe Breast Cancer Screening Sales, Revenue and Market Share by Country
6.1.1 Europe Breast Cancer Screening Sales and Market Share by Country (2014-2019)
6.1.2 Europe Breast Cancer Screening Revenue and Market Share by Country (2014-2019)
6.2 Germany Breast Cancer Screening Sales and Growth Rate (2014-2019)
6.3 UK Breast Cancer Screening Sales and Growth Rate (2014-2019)
6.4 France Breast Cancer Screening Sales and Growth Rate (2014-2019)
6.5 Russia Breast Cancer Screening Sales and Growth Rate (2014-2019)
6.6 Italy Breast Cancer Screening Sales and Growth Rate (2014-2019)
7 Asia-Pacific Breast Cancer Screening by Country
7.1 Asia-Pacific Breast Cancer Screening Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Breast Cancer Screening Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Breast Cancer Screening Revenue and Market Share by Country (2014-2019)
7.2 China Breast Cancer Screening Sales and Growth Rate (2014-2019)
7.3 Japan Breast Cancer Screening Sales and Growth Rate (2014-2019)
7.4 Korea Breast Cancer Screening Sales and Growth Rate (2014-2019)
7.5 India Breast Cancer Screening Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Breast Cancer Screening Sales and Growth Rate (2014-2019)
8 South America Breast Cancer Screening by Country
8.1 South America Breast Cancer Screening Sales, Revenue and Market Share by Country
8.1.1 South America Breast Cancer Screening Sales and Market Share by Country (2014-2019)
8.1.2 South America Breast Cancer Screening Revenue and Market Share by Country (2014-2019)
8.2 Brazil Breast Cancer Screening Sales and Growth Rate (2014-2019)
8.3 Argentina Breast Cancer Screening Sales and Growth Rate (2014-2019)
8.4 Colombia Breast Cancer Screening Sales and Growth Rate (2014-2019)
9 Middle East and Africa Breast Cancer Screening by Countries
9.1 Middle East and Africa Breast Cancer Screening Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Breast Cancer Screening Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Breast Cancer Screening Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Breast Cancer Screening Sales and Growth Rate (2014-2019)
9.3 Turkey Breast Cancer Screening Sales and Growth Rate (2014-2019)
9.4 Egypt Breast Cancer Screening Sales and Growth Rate (2014-2019)
9.5 Nigeria Breast Cancer Screening Sales and Growth Rate (2014-2019)
9.6 South Africa Breast Cancer Screening Sales and Growth Rate (2014-2019)
10 Global Breast Cancer Screening Market Segment by Type
10.1 Global Breast Cancer Screening Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Breast Cancer Screening Sales and Market Share by Type (2014-2019)
10.1.2 Global Breast Cancer Screening Revenue and Market Share by Type (2014-2019)
10.2 Mammography Screening Sales Growth and Price
10.2.1 Global Mammography Screening Sales Growth (2014-2019)
10.2.2 Global Mammography Screening Price (2014-2019)
10.3 Breast Magnetic Resonance Imaging (MRI) Screening Sales Growth and Price
10.3.1 Global Breast Magnetic Resonance Imaging (MRI) Screening Sales Growth (2014-2019)
10.3.2 Global Breast Magnetic Resonance Imaging (MRI) Screening Price (2014-2019)
10.4 Breast Ultrasound Screening Sales Growth and Price
10.4.1 Global Breast Ultrasound Screening Sales Growth (2014-2019)
10.4.2 Global Breast Ultrasound Screening Price (2014-2019)
11 Global Breast Cancer Screening Market Segment by Application
11.1 Global Breast Cancer Screening Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Clinic Sales Growth (2014-2019)
12 Breast Cancer Screening Market Forecast (2019-2024)
12.1 Global Breast Cancer Screening Sales, Revenue and Growth Rate (2019-2024)
12.2 Breast Cancer Screening Market Forecast by Regions (2019-2024)
12.2.1 North America Breast Cancer Screening Market Forecast (2019-2024)
12.2.2 Europe Breast Cancer Screening Market Forecast (2019-2024)
12.2.3 Asia-Pacific Breast Cancer Screening Market Forecast (2019-2024)
12.2.4 South America Breast Cancer Screening Market Forecast (2019-2024)
12.2.5 Middle East and Africa Breast Cancer Screening Market Forecast (2019-2024)
12.3 Breast Cancer Screening Market Forecast by Type (2019-2024)
12.3.1 Global Breast Cancer Screening Sales Forecast by Type (2019-2024)
12.3.2 Global Breast Cancer Screening Market Share Forecast by Type (2019-2024)
12.4 Breast Cancer Screening Market Forecast by Application (2019-2024)
12.4.1 Global Breast Cancer Screening Sales Forecast by Application (2019-2024)
12.4.2 Global Breast Cancer Screening Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Breast Cancer Screening Picture
Table Product Specifications of Breast Cancer Screening
Figure Global Sales Market Share of Breast Cancer Screening by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
